Outbreak Column 15: Carbapenemase-producing Enterobacteriaceae

Anon. (2014a) Guidance for control of infections with carbapenem-resistant or carbapenemase-producing enterobacteriaceae in acute care facilities. Morbidity and M ortality Weekly Report 58(10): 256–60.

Anon. (2014b) Notes from the field: New Delhi metallo-beta-lactamase-producing Escherichia coli associated with endoscopic retrograde cholangiopancreatography – Illinois, 2013. MMWR Morbidity and M ortality Weekly Report 62(51–52): 1051.

Bagshawe KD Blowers R Lidwell OM . (1978) Isolating patients in hospital to control infection. Part I Sources and routes of infection. British Medical Journal 2(6137): 609–13.

Bhargava A Hayakawa K Silverman E Haider S Alluri KC Datla S Diviti S Kuchipudi V Muppavarapu KS Lephart PR Marchaim D Kaye KS . (2014) Risk factors for colonization due to carbapenem-resistant Enterobacteriaceae among patients exposed to long-term acute care and acute care facilities. Infection Control and Hospital Epidemiology 35(4): 398–405.

Burns K Morris D Murchan S Cunney R Smyth E Power M Schaffer K Collins C Sheahan A Cormican M Fitzpatrick F. (2013) Carbapenemase-producing Enterobacteriaceae in Irish critical care units: results of a pilot prevalence survey, June 2011. Journal of Hospital Infection 83(1): 71–3.

Calfee D Jenkins SG . (2008) Use of active surveillance cultures to detect asymptomatic colonization with carbapenem-resistant Klebsiella pneumoniae in intensive care unit patients. Infection Control and Hospital Epidemiology 29(10): 966–8.

Canton R Akova M Carmeli Y Giske CG Glupczynski Y Gniadkowski M Livermore DM Miriagou V Naas T Rossolini GM Samuelsen O Seifert H Woodford N Nordmann P. (2012) Rapid evolution and spread of carbapenemases among Enterobacteriaceae in Europe. Clinical Microbiology and Infection 18(5): 413–31.

Carmeli Y Akova M Cornaglia G Daikos GL Garau J Harbarth S Rossolini GM Souli M Giamarellou H. (2010) Controlling the spread of carbapenemase-producing Gram-negatives: therapeutic approach and infection control. Clinical Microbiology and Infection 16(2): 102–11.

Catchpole M . (2014) Health Protection – CPE Level 3 Incident: carbapenemase-producing Enterobacteriaceae. PHE NIRP Level 3 2014/13.

Centers for Disease Control and Prevention. (2012) Guidance for control of carbapenem-resistant Enterobacteriaceae (CRE). 2012 CRE Toolkit. CDC: Atlanta.

Curran E . (2011) Intravenous drug preparation: the infection risks. British Journal of Nursing 20(14): S4, S6–S4, S8.

Curran ET . (2014a) Outbreak Column 12: Nosocomial Staphylococcus aureus outbreaks (part 1). Journal of Infection Prevention 15(1): 37–40.

Curran ET . (2014b) Outbreak Column 13: Nosocomial Staphylococcus aureus outbreaks (part 2 –guidelines). Journal of Infection Prevention 15(2): 69–73.

Daikos GL Petrikkos P Psichogiou M Kosmidis C Vryonis E Skoutelis A Georgousi K Tzouvelekis LS Tassios PT Bamia C Petrikkos G. (2009) Prospective observational study of the impact of VIM-1 metallo-beta-lactamase on the outcome of patients with Klebsiella pneumoniae bloodstream infections. Antimicrobial Agents and Chemotherapy 53(5): 1868–73.

Day KM Ali S Mirza IA Sidjabat HE Silvey A Lanyon CV Cummings SP Abbasi SA Raza MW Paterson DL Perry JD . (2013) Prevalence and molecular characterization of Enterobacteriaceae producing NDM-1 carbapenemase at a military hospital in Pakistan and evaluation of two chromogenic media. Diagnostic Microbiology and Infectious Disease 75(2): 187–91.

Dijkshoorn L Nemec A Seifert H. (2007) An increasing threat in hospitals: multidrug-resistant Acinetobacter baumannii. Nature Reviews Microbiology 5(12): 939–51.

ECDC 2013 (European Centre for Disease Prevention and Control). (2013) Antimicrobial resistance surveillance in Europe 2012. Annual Report of the European Antimicrobial Resistance Surveillance network (EARS-Net). ECDC: Stockholm.

ECDC Working Group 2013 (European Centre for Disease Prevention and Control). (2013) ECDC Technical Report: Risk assessment on the spread of carbapenemase-producing Enterobacteriaceae (CPE) through patient transfer between healthcare facilities, with special emphasis on cross-border transfer. ECDC: Stockholm.

Falagas MS Tansarli GS Karageorgopoulos DE Vardakas KZ . (2014) Deaths attributable to carbapenemase-resistant Enterobacteriaceae Infections. Emerging Infectious Diseases 20(7): 1170–5.

Farrell DJ Morrissey I De Rubeis D Robbins M Felmingham D. (2003) A UK multicentre study of the antimicrobial susceptibility of bacterial pathogens causing urinary tract infection. Journal of Infection 46(2): 94–100.

Garner JS . (1996) Guideline for isolation precautions in hospitals. Part I. Evolution of isolation practices, Hospital Infection Control Practices Advisory Committee. American Journal of Infection Control 24(1): 24–31.

Gray J Arvelo W McCracken J Lopez B Lessa FC Kitchel B Wong B Reyes L Lindblade K. (2012) An outbreak of Klebsiella pneumoniae late-onset sepsis in a neonatal intensive care unit in Guatemala. American Journal of Infection Control 40(6): 516–20.

Gupta N Limbago BM Patel JB Kallen AJ . (2011) Carbapenem-resistant Enterobacteriaceae: epidemiology and prevention. Clinical Infectious Diseases 53(1): 60–7.

Haverkate MR Derde LP Brun-Buisson C Bonten MJ Bootsma MC . (2014) Duration of colonization with antimicrobial-resistant bacteria after ICU discharge. Intensive Care Medicine 40(4): 564–71.

Health Protection Agency. (2012) English national point prevalence survey on healthcare-associated infections and antimicrobial use, 2011: Preliminary data. Health Protection Agency: London.

Health Protection Scotland 2R. (2012) Scottish national point prevalence survey of healthcare associated infection and antimicrobial prescribing 2011. HPS: Glasgow.

Health Protection Scotland. (2014) National infection prevention and control manual: chapter 1: Standard infection control precautions (SICPs). HPS: Glasgow.

Hidron AI Edwards JR Patel J Horan TC Sievert DM Pollock DA Fridkin SK . (2008) NHSN annual update: antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006–2007. Infection Control and Hospital Epidemiology 29(11): 996–1011.

Ho J Tambyah PA Paterson DL . (2010) Multiresistant Gram-negative infections: a global perspective. Current Opinion in Infectious Diseases 23(6): 546–53.

HPS Interim Working Group. (2013) Interim guidance: non-prescribing control measures to prevent cross transmission of carbapenemase-producing Enterobacteriaceae in acute settings. Health Protection Scotland: Glasgow.

Khan AS Dancer SJ Humphreys H. (2012) Priorities in the prevention and control of multidrug-resistant Enterobacteriaceae in hospitals. Journal of Hospital Infection 82(2): 85–93.

Leung V Loo VG Frenette C Domingo MC Bourgault AM Mulvey MR Robson HG . (2012) First Canadian outbreak of Enterobacteriaceae-expressing Klebsiella pneumoniae carbapenemase type 3. Canadian Journal of Infectious Diseases and Medical Microbiology 23(3): 117–20.

Levy HG Gould I Endimiani A Pardo PR Daikos G Hsueh PR Mehtar S Petrikkos G Casellas JM Daciuk L Paciel D Novelli A Saginur R Pryluka D Medina J Savio E. (2013) Detection, treatment, and prevention of carbapenemase-producing Enterobacteriaceae: recommendations from an International Working Group. Journal of Chemotherapy 25(3): 129–40.

Loveday HP Wilson JA Kerr K Pitchers R Walker JT Browne J. (2014a) Association between healthcare water systems and Pseudomonas aeruginosa infections: a rapid systematic review. Journal of Hospital Infection 86(1): 7–15.

Loveday HP Wilson JA Pratt RJ Golsorkhi M Tingle A Bak A Browne J Prieto J Wilcox M. (2014b) epic3: national evidence-based guidelines for preventing healthcare-associated infections in NHS hospitals in England. Journal of Hospital Infection 86 Suppl 1: S1–S70.

Lowe C Willey B O’Shaughnessy A Lee W Lum M Pike K Larocque C Dedier H Dales L Moore C McGeer A. (2012) Outbreak of extended-spectrum beta-lactamase-producing Klebsiella oxytoca infections associated with contaminated handwashing sinks (1). Emerging Infectious Diseases 18(8): 1242–7.

Lubbert C Lippmann N Busch T Kaisers UX Ducomble T Eckmanns T Rodloff AC . (2014) Long-term carriage of Klebsiella pneumoniae carbapenemase-2-producing K pneumoniae after a large single-center outbreak in Germany. American Journal of Infection Control 42(4): 376–80.

Nordmann P Naas T Poirel L. (2011) Global spread of Carbapenemase-producing Enterobacteriaceae. Emerging Infectious Diseases 17(10): 1791–8.

Nordmann P Poirel L. (2013) Strategies for identification of carbapenemase-producing Enterobacteriaceae. Journal of Antimicrobial Chemotherapy 68(3): 487–9.

Patel G Huprikar S Factor SH Jenkins SG Calfee DP . (2008) Outcomes of carbapenem-resistant Klebsiella pneumoniae infection and the impact of antimicrobial and adjunctive therapies. Infection Control and Hospital Epidemiology 29(12): 1099–106.

Paterson DL . (2006) The epidemiological profile of infections with multidrug-resistant Pseudomonas aeruginosa and Acinetobacter species. Clinical Infectious Diseases 43 Suppl 2: S43–S48.

Peleg AY Hooper DC . (2010) Hospital-acquired infections due to gram-negative bacteria. New England Journal of Medicine 362(19): 1804–13.

Public Health England Working Group. (2013) Acute trust tooklit for the early detection, management and control of carbapenemase-producing Enterobacteriaceae. PHE: London.

Queenan AM Bush K. (2007) Carbapenemases: the versatile beta-lactamases. Clinical Microbiology Reviews 20(3): 440–58, table.

Schwaber MJ Carmeli Y. (2014) An ongoing national intervention to contain the spread of carbapenem-resistant enterobacteriaceae. Clinical Infectious Diseases 58(5): 697–703.

Schwaber MJ Lev B Israeli A Solter E Smollan G Rubinovitch B Shalit I Carmeli Y. (2011) Containment of a country-wide outbreak of carbapenem-resistant Klebsiella pneumoniae in Israeli hospitals via a nationally implemented intervention. Clinical Infectious Diseases 52(7): 848–55.

Smith GC Pell JP . (2003) Parachute use to prevent death and major trauma related to gravitational challenge: systematic review of randomised controlled trials. British Medical Journal 327(7429):1459–61.

Snitkin ES Zelazny AM Thomas PJ Stock F Henderson DK Palmore TN Segre JA . (2012) Tracking a hospital outbreak of carbapenem-resistant Klebsiella pneumoniae with whole-genome sequencing. Science Translational Medicine 4(148): 148ra116.

Tacconelli E Cataldo MA Dancer SJ De Angelis G Falcone M Frank U Kahlmeter G Pan A Petrosillo N Rodriguez-Bano J Singh N Venditti M Yokoe DS Cookson B. (2014) ESCMID guidelines for the management of the infection control measures to reduce transmission of multidrug-resistant Gram-negative bacteria in hospitalized patients. Clinical Microbiology and Infection 20 Suppl 1: 1–55.

Vlek AL Cooper BS Kypraios T Cox A Edgeworth JD Auguet OT . (2013) Clustering of antimicrobial resistance outbreaks across bacterial species in the intensive care unit. Clinical Infectious Diseases 57(1): 65–76.

Weick KE Sutcliffe M Obstfeld D. (1999) Organizing for high reliability: processes of collective mindfulness. In: Sutton RSSBM (ed.), Research in organizational behavior. 1st edn. Jai Press: Stanford: 81–123.

Wiener-Well Y Rudensky B Yinnon AM Kopuit P Schlesinger Y Broide E Lachish T Raveh D. (2010) Carriage rate of carbapenem-resistant Klebsiella pneumoniae in hospitalised patients during a national outbreak. Journal of Hospital Infection 74(4): 344–9.

World Health Organization. (2007) Standard precautions in healthcare: aide-memoire. Epidemic and pandemic alert and response. WHO: Geneva.

World Health Organization. (2009a) Hand hygiene: why, how and when? World Health Organization online resource: www.who.int/entity/gpsc/5may/Hand_Hygiene_Why_How_and_When_Brochure.pdf?ua=1 (accessed 19 May 2014).

World Health Organization. (2009b) WHO guidelines on hand hygiene in health care: first global patient safety challenge clean care is safer care. World Health Organization online resource: http://whqlibdoc.who.int/publications/2009/9789241597906_eng.pdf?ua=1 (accessed 19 May 2014), 1–259.

Zarb P Coignard B Griskeviciene J Muller A Vankerckhoven V Weist K Goossens M Vaerenberg S Hopkins S Catry B Monnet D Goossens H Suetens C. (2012) The European Centre for Disease Prevention and Control (ECDC) pilot point prevalence survey of healthcare-associated infections and antimicrobial use. Eurosurveillance 17(46).